MDxHealth S.A. (MDXH )
Currency in USD Disclaimer
Subscribe Now for Delta3 AI Alerts
Don’t miss out on top stock picks and market insights. Subscribe to Delta3 AI Alerts for real-time updates and expert analysis straight to your inbox. Stay informed and maximize your investment potential.
Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
- Symbol MDXH
- Company MDxHealth S.A.
- Price $0.72
- Changes Percentage -5.15
- Change -0.0391
- Day Low $0.72
- Day High $0.79
- Year High $5.33
- Year Low $0.4
- Market Cap $21,650,145
- Price Avg 50 EMA (D) $0.57
- Price Avg 200 EMA (D) $2.64
- Exchange NASDAQ
- Volume 55,567
- Average Volume 845,562
- Open $0.78
- Previous Close $0.76
- EPS -0.38
- PE -1.11
- Earnings Announcement 2026-08-13 20:00:00
- Shares Outstanding $51,364,520
Company brief: MDXHEALTH S.A. (MDXH )
- Healthcare
- Medical - Diagnostics & Research
- Mr. Michael K. McGarrity
- https://mdxhealth.com
- BE
- N/A
- 11-04-2021
- US58286E1029
MDxHealth SA, a commercial-stage precision diagnostics company, provides urologic solutions in the United States, the Netherlands, Belgium, Spain, Poland, Italy, rest of European Union, and internationally. Its novel prostate cancer genomic testing solutions are SelectMDx, a non-invasive urine test; and ConfirmMDx, an epigenetic test, which provide physicians with a clinical pathway to identify clinically prostate cancer while minimizing the use of invasive procedures that are prone to complications. The company was formerly known as OncoMethylome Sciences SA and changed its name to MDxHealth SA in October 2010. MDxHealth SA was incorporated in 2003 and is headquartered in Herstal, Belgium.